All Phenotypes Cul9<tm1.2Yxi> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Cul9^tm1.2Yxi
targeted mutation 1.2, Yue Xiong
MGI:5007737

Summary

5 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Cul9^tm1.2Yxi/Cul9^tm1.2Yxi	involves: 129P2/OlaHsd * C57BL/6 * FVB/N	MGI:5007742
ht2	Cul9^tm1.2Yxi/Cul9⁺	involves: 129P2/OlaHsd * C57BL/6 * FVB/N	MGI:5007741
cx3	Cul9^tm1.2Yxi/Cul9^tm1.2Yxi Trp53^tm1Tyj/Trp53^tm1Tyj	involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB/N	MGI:5007743
cx4	Cul9^tm1.2Yxi/Cul9⁺ Tg(IghMyc)22Bri/0	involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL	MGI:5007744
cx5	Cul9^tm1.2Yxi/Cul9^tm1.2Yxi Tg(IghMyc)22Bri/0	involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL	MGI:5007745

Allelic Composition	Cul9^tm1.2Yxi/Cul9^tm1.2Yxi
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cul9^tm1.2Yxi mutation (0 available); any Cul9 mutation (108 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

increased ovary tumor incidence ( J:170976 )

• 1 of 12 mice

increased pituitary gland tumor incidence ( J:170976 )

• 8 of 28 mice

mortality/aging

decreased tumor-free survival time ( J:170976 )

• tumor-free survival is 19.9 months compared with 26.4 months for wild-type mice

liver/biliary system

increased liver tumor incidence ( J:170976 )

• 2 of 28 mice

neoplasm

increased tumor incidence ( J:170976 )

• 22 of 28 mice exhibit tumors including lymphoma, sarcoma, and tumors in the pituitary, lung, liver, and ovary

increased ovary tumor incidence ( J:170976 )

• 1 of 12 mice

increased pituitary gland tumor incidence ( J:170976 )

• 8 of 28 mice

increased incidence of tumors by chemical induction ( J:170976 )

• DEN-treated mice develop more tumors than similarly treated wild-type mice

increased liver tumor incidence ( J:170976 )

• 2 of 28 mice

increased lymphoma incidence ( J:170976 )

• 4 of 28 mice

increased sarcoma incidence ( J:170976 )

• 2 of 28 mice

increased lung tumor incidence ( J:170976 )

• 4 of 28 mice

cellular

cellular phenotype ( J:170976 )

N	• mouse embryonic fibroblasts exhibit normal cell cycle progression

decreased cellular sensitivity to gamma-irradiation ( J:170976 )

• in embryonic stem, thymus, and spleen cells

decreased cellular sensitivity to ultraviolet irradiation ( J:170976 )

• in mouse embryonic fibroblasts

nervous system

increased pituitary gland tumor incidence ( J:170976 )

• 8 of 28 mice

reproductive system

increased ovary tumor incidence ( J:170976 )

• 1 of 12 mice

growth/size/body

decreased body weight ( J:170976 )

homeostasis/metabolism

increased incidence of tumors by chemical induction ( J:170976 )

• DEN-treated mice develop more tumors than similarly treated wild-type mice

respiratory system

increased lung tumor incidence ( J:170976 )

• 4 of 28 mice

Allelic Composition	Cul9^tm1.2Yxi/Cul9⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cul9^tm1.2Yxi mutation (0 available); any Cul9 mutation (108 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

increased insulinoma incidence ( J:170976 )

• in 1 of 23 mice

increased pituitary gland tumor incidence ( J:170976 )

• 4 of 23 mice

mortality/aging

decreased tumor-free survival time ( J:170976 )

• tumor-free survival is 20.8 months compared with 26.4 months for wild-type mice

neoplasm

increased tumor incidence ( J:170976 )

• 17 of 23 mice develop tumors along the same spectrum as homozygous mice

increased insulinoma incidence ( J:170976 )

• in 1 of 23 mice

increased pituitary gland tumor incidence ( J:170976 )

• 4 of 23 mice

increased incidence of tumors by chemical induction ( J:170976 )

• DEN-treated mice develop more tumors than similarly treated wild-type mice

increased lymphoma incidence ( J:170976 )

• in 3 of 23 mice

increased sarcoma incidence ( J:170976 )

• in 3 of 23 mice

increased lung tumor incidence ( J:170976 )

• 5 of 23 mice

nervous system

increased pituitary gland tumor incidence ( J:170976 )

• 4 of 23 mice

homeostasis/metabolism

increased incidence of tumors by chemical induction ( J:170976 )

• DEN-treated mice develop more tumors than similarly treated wild-type mice

respiratory system

increased lung tumor incidence ( J:170976 )

• 5 of 23 mice

Allelic Composition	Cul9^tm1.2Yxi/Cul9^tm1.2Yxi Trp53^tm1Tyj/Trp53^tm1Tyj
Genetic Background	involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cul9^tm1.2Yxi mutation (0 available); any Cul9 mutation (108 available)
Trp53^tm1Tyj mutation (12 available); any Trp53 mutation (232 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:170976 )

N	• mice exhibit the same tumors-free survival time as Trp53^tm1Tyj homozygotes

neoplasm

neoplasm ( J:170976 )

N	• mice exhibit the same tumors-free survival time as Trp53^tm1Tyj homozygotes

Allelic Composition	Cul9^tm1.2Yxi/Cul9⁺ Tg(IghMyc)22Bri/0
Genetic Background	involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cul9^tm1.2Yxi mutation (0 available); any Cul9 mutation (108 available)
Tg(IghMyc)22Bri mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:170976 )

• lymphoma-free survival is 108.9 months compared with 126.4 months for Tg(IghMyc)22Bri mice

neoplasm

abnormal tumor pathology ( J:170976 )

• lymphoma cell clusters spread throughout the liver parenchyma and exhibit various degrees of lung and pancreas infiltration unlike in Tg(IghMyc)22Bri mice

increased lymphoma incidence ( J:170976 )

• 3 of 5 mice younger than 2 months of age develop lymphomas unlike Tg(IghMyc)22Bri mice

• by 5 months, 16 of 20 of mice develop lymphomas compared with 6 of 9 Tg(IghMyc)22Bri mice

increased B cell derived lymphoma incidence ( J:170976 )

• all lymphomas are B cell or pre-B cell lymphomas

Allelic Composition	Cul9^tm1.2Yxi/Cul9^tm1.2Yxi Tg(IghMyc)22Bri/0
Genetic Background	involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cul9^tm1.2Yxi mutation (0 available); any Cul9 mutation (108 available)
Tg(IghMyc)22Bri mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:170976 )

• lymphoma-free survival is 85.1 months compared with 126.4 months for Tg(IghMyc)22Bri mice

neoplasm

abnormal tumor pathology ( J:170976 )

• lymphoma cell clusters spread throughout the liver parenchyma and exhibit various degrees of lung and pancreas infiltration unlike in Tg(IghMyc)22Bri mice

increased lymphoma incidence ( J:170976 )

• mice develop lymphomas by 25 days of age

• 3 of 5 mice younger than 2 months of age develop lymphomas unlike Tg(IghMyc)22Bri mice

• by 5 months, 10 of 10 of mice develop lymphomas compared with 6 of 9 Tg(IghMyc)22Bri mice

increased B cell derived lymphoma incidence ( J:170976 )

• all lymphomas are B cell or pre-B cell lymphomas

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/30/2024 MGI 6.23